Bilberry Pharmaceutical Pvt Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Rozglyn MV 1mg/500mg/0.3mg Tablet is an anti-diabetic drug used to treat type 2 diabetes mellitus in adults by controlling blood sugar levels.
Tablet
Rozglyn MV 1mg/500mg/0.3mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. The medicine should be taken with food to avoid an upset stomach. Regular monitoring of liver function may be required. Consult your doctor for any symptoms such as abdominal pain, loss of appetite, or jaundice.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Rozglyn MV 1mg/500mg/0.3mg Tablet is to be taken on an empty stomach.
Rozglyn MV 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines.
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Rozglyn MV 1mg/500mg/0.3mg Tablet is a combination medication containing Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, in combination with a healthy diet and regular exercise. Glimepiride increases insulin release from the pancreas, Metformin lowers glucose production in the liver and improves insulin sensitivity, and Voglibose reduces postprandial glucose levels. This medication is not suitable for treating type 1 DM.
Common side effects of Rozglyn MV 1mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any of these symptoms, consult your doctor for guidance.
Rozglyn MV 1mg/500mg/0.3mg Tablet should be avoided in patients with known allergies to its components or excipients, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis. Consult your doctor before taking this medication if you have any of these conditions.
No, it is not recommended to consume alcohol while taking Rozglyn MV 1mg/500mg/0.3mg Tablet. This may increase the risk of hypoglycemia and lactic acidosis. Consult your doctor for personalized advice on alcohol consumption.
Yes, Rozglyn MV 1mg/500mg/0.3mg Tablet can cause hypoglycemia (low blood sugar). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. Regularly monitor your blood sugar levels and keep glucose tablets, honey, or fruit juice with you to manage hypoglycemia. Consult your doctor if you experience any of these symptoms.
Store Rozglyn MV 1mg/500mg/0.3mg Tablet in its original packaging, tightly closed. Dispose of any unused medication and ensure it is not consumed by pets, children, or other individuals. Follow the storage instructions provided on the packaging or label.